89bio, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
March 10, 2023 at 06:36 pm IST
89bio, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported net loss was USD 24.6 million compared to USD 26.29 million a year ago. Basic loss per share from continuing operations was USD 0.48 compared to USD 1.3 a year ago. Diluted loss per share from continuing operations was USD 0.48 compared to USD 1.3 a year ago.
For the full year, the company reported net loss was USD 102.03 million compared to USD 90.12 million a year ago. Basic loss per share from continuing operations was USD 2.93 compared to USD 4.48 a year ago. Diluted loss per share from continuing operations was USD 2.93 compared to USD 4.48 a year ago.